SCHEMBL8042419

SCHEMBL8042419

Cc1ccc(OC2CCC(O)CC2)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.51
SYK P43405 1/20 0.44
CSNK2A1 P68400 2/20 0.44
KMO O15229 7/20 0.44
GRM2 Q14416 2/20 0.41
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
P2RX3 P56373 3/20 0.39
HRH1 P35367 1/20 0.39
CCR3 P51677 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12908040 1.00 RORC (0.51) RORCSYKCSNK2A1KMOGRM2
SCHEMBL12908041 1.00 RORC (0.51) RORCSYKCSNK2A1KMOGRM2
SCHEMBL14294081 0.92 RORC (0.54) RORCSYKCSNK2A1KMOMAPT
SCHEMBL17708435 0.85 RORC (0.42) RORCSYKCSNK2A1MAPTRAB9A
SCHEMBL12908030 0.85 CSNK2A1 (0.59) RORCSYKCSNK2A1KMORAB9A
SCHEMBL13678433 0.85 CSNK2A1 (0.55) RORCSYKCSNK2A1KMOMAPT
SCHEMBL5369456 0.81 HTR2C (0.51) RORCSYKCSNK2A1HRH1
SCHEMBL12908033 0.81 SYK (0.67) RORCSYKCSNK2A1GRM2P2RX3
SCHEMBL19139905 0.80 RORC (0.45) RORCSYKCSNK2A1KMONPSR1
SCHEMBL8042420 0.80 RORC (0.45) RORCSYKCSNK2A1KMONPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2220083-B1 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS JANSSEN PHARMACEUTICALS INC (US) 2017-07-19 EP disclosed
WO-2009062676-A2 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. (US) 2009-05-22 WO disclosed